RVMD

Revolution Medicines (RVMD) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

SEC Filings

Vanguard Capital Management Reports 5.13% Stake In Revolution Medicines

The passive position covers 10,999,044 shares, as the drugmaker's new pancreatic cancer pill reshapes its field.

SEC Filings

Revolution Medicines Took A $250 Million Royalty Pharma Loan And Passed On A Royalty Sale Worth Up To $250 Million

An 8-K shows the drugmaker drew the first loan tranche and declined a separate royalty sale, with $1 billion in options still open.